SS-31 vs MOTS-c: How Two Mitochondrial Peptides Differ
Search for mitochondrial peptides and two names come up: SS-31 (elamipretide) and MOTS-c. They’re routinely discussed together, often as if they were interchangeable options for the same goal. They aren’t. They intervene at different levels of mitochondrial biology, and the research behind each has a different shape and a different maturity.
This page is a research overview. Both compounds are supplied for laboratory research use only, are not approved by Health Canada for therapeutic use, and are not for human or veterinary consumption.
The short version
SS-31 is structural. It concentrates in the inner mitochondrial membrane and binds cardiolipin — a phospholipid that helps hold cristae in shape and keeps the electron transport chain organised. The research question is whether stabilising that architecture improves the efficiency of energy transfer and reduces electron leak.
MOTS-c is regulatory. Conceptually it isn’t applied from outside the system at all — it’s a peptide encoded within mitochondrial DNA itself. Research focuses on its signalling role, particularly through the AMPK pathway, and on how it appears to participate in metabolic adaptation under stress.
One is studied as a way to support the machinery. The other is studied as part of how the cell decides what that machinery should be doing.
MOTS-c vs SS-31: where the evidence actually stands
This is where the two diverge most, and it’s the part most comparisons skip.
SS-31 has the deeper clinical record. It has been through human trials, including in primary mitochondrial myopathy, and the results have been genuinely mixed — some endpoints moved, several primary endpoints did not. That isn’t a reason to dismiss it, but it is a reason to be sceptical of confident claims. A compound that has reached late-stage trials and produced ambiguous results is better characterised than most research peptides, and the ambiguity is itself information.
MOTS-c is earlier. Most of what’s known comes from cell and animal models, plus observational work on its expression in humans. It’s a genuinely interesting area of mitochondrial biology, but the human data is thinner, and anyone presenting it as established is getting ahead of the literature.
SS-31 and MOTS-c together: is there evidence for the stack?
This is the question people actually arrive with, so here’s the direct answer: there is no published research testing SS-31 and MOTS-c in combination.
Mechanistically you can see why the pairing gets discussed — one line of research targets membrane structure, the other targets metabolic signalling, and those aren’t competing hypotheses. In principle they address different layers. But “in principle they don’t overlap” is not the same as “combining them has been shown to help,” and no study has bridged that gap. Anyone who tells you the combination is proven is describing an idea, not a finding.
For a research context, the more useful framing is that these are two distinct hypotheses about mitochondrial function — not two doses of the same one.
What to check before you buy either one
Both compounds are widely sold, and quality varies more than price does. The questions worth asking any supplier:
- Is there a valid certificate of analysis?
- What date was the testing done?
- Does the COA match the batch you actually received?
- Is there a batch number, manufacturing date and expiry printed on the vial itself?
- Where was the testing done — in Canada, or offshore?
- Can you look up your specific result on the testing laboratory’s own website?
That last one matters more than it sounds. A PDF hosted by the seller is a document the seller controls. A code you verify with the laboratory is not.
Every Quantum vial carries a batch number matching one specific certificate, tested by Peptide Test Canada — an independent Canadian laboratory — and the code on that certificate can be checked on their site rather than ours. We’re not aware of another Canadian supplier that does all three. If you find one, tell us and we’ll say so here.
View the SS-31 research profile →
View the MOTS-c research profile →
SS-31 (elamipretide) 50mg — research use only →
MOTS-c — research use only →
See our certificates of analysis →
Frequently asked questions
Is SS-31 the same as elamipretide?
Yes. Elamipretide is the compound’s formal name; SS-31 is the research designation used in most of the earlier literature. You’ll see both used interchangeably.
Is SS-31 or MOTS-c better?
They aren’t substitutes, so “better” depends entirely on the research question. SS-31 is studied for mitochondrial membrane structure and electron transport efficiency; MOTS-c is studied for metabolic signalling through AMPK. SS-31 has more human trial data; MOTS-c is earlier-stage.
Can SS-31 and MOTS-c be used together?
No published study has tested them in combination. Their mechanisms don’t obviously conflict, but absence of conflict isn’t evidence of benefit. Both are supplied for research use only.
What does MOTS-c actually do?
MOTS-c is a peptide encoded in mitochondrial DNA rather than nuclear DNA. The research describes it as a signalling molecule: it appears to act through the AMPK pathway and to influence how cells respond to metabolic stress. Its mechanism of action is therefore regulatory rather than structural — it is studied for what it signals to the cell, not for repairing the mitochondrion itself. Most of that work remains preclinical.
How does MOTS-c compare to NAD+?
They sit at different points in the same system. NAD+ is a coenzyme consumed directly in energy metabolism; MOTS-c is a signalling peptide studied for how metabolic pathways are regulated. Comparing them is closer to comparing a fuel with a thermostat than comparing two versions of the same thing. Our NAD+ research overview covers the coenzyme side in more detail.
Are these legal in Canada?
Both may be sold in Canada for laboratory research use only. Neither is a Health Canada-approved drug, and neither is intended for human or veterinary use.
How do I verify purity?
Every batch ships with a batch-specific certificate of analysis showing HPLC purity, and the certificate code can be independently verified at Peptide Test Canada.
For research use only. Not for human or veterinary use. Not evaluated by Health Canada for safety, efficacy or quality.
